iShares Biotechnology ETF (NASDAQ:IBB) Holdings Boosted by Main Management ETF Advisors LLC

Main Management ETF Advisors LLC boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 593,370 shares of the financial services provider’s stock after purchasing an additional 14,535 shares during the period. iShares Biotechnology ETF accounts for 4.1% of Main Management ETF Advisors LLC’s investment portfolio, making the stock its 8th biggest holding. Main Management ETF Advisors LLC’s holdings in iShares Biotechnology ETF were worth $86,395,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. National Bank of Canada FI grew its holdings in shares of iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after acquiring an additional 229 shares in the last quarter. EP Wealth Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 8.0% during the 3rd quarter. EP Wealth Advisors LLC now owns 9,677 shares of the financial services provider’s stock valued at $1,409,000 after acquiring an additional 713 shares in the last quarter. Kovitz Investment Group Partners LLC grew its holdings in shares of iShares Biotechnology ETF by 38.0% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 4,192 shares of the financial services provider’s stock valued at $610,000 after acquiring an additional 1,154 shares in the last quarter. Quantinno Capital Management LP purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $244,000. Finally, Pinnacle Family Advisors LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $3,347,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.0 %

IBB stock opened at $141.30 on Friday. iShares Biotechnology ETF has a 1 year low of $123.27 and a 1 year high of $150.57. The company has a fifty day simple moving average of $142.34 and a 200 day simple moving average of $142.15.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.